OCA
Octagon Capital Advisors’s Dianthus Therapeutics DNTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.6M | Hold |
2,341,667
| – | – | 9.57% | 1 |
|
|
2025
Q1 | $42.5M | Buy |
2,341,667
+231,500
| +11% | +$4.2M | 8.22% | 3 |
|
|
2024
Q4 | $46M | Buy |
2,110,167
+363,500
| +21% | +$7.92M | 7.57% | 3 |
|
|
2024
Q3 | $47.8M | Hold |
1,746,667
| – | – | 7.44% | 4 |
|
|
2024
Q2 | $45.2M | Buy |
1,746,667
+366,000
| +27% | +$9.47M | 7.1% | 2 |
|
|
2024
Q1 | $41.4M | Buy |
1,380,667
+826,667
| +149% | +$24.8M | 4.96% | 3 |
|
|
2023
Q4 | $5.76M | Buy |
554,000
+74,000
| +15% | +$770K | 0.92% | 23 |
|
|
2023
Q3 | $6.56M | Sell |
480,000
-70,000
| -13% | -$957K | 1.01% | 19 |
|
|
2023
Q2 | $417K | Buy |
+550,000
| New | +$417K | 0.06% | 38 |
|